scholarly journals Neuroprotective effects of enriched environment housing after transient global cerebral ischaemia are associated with the upregulation of insulin‐like growth factor‐1 signalling

2015 ◽  
Vol 41 (4) ◽  
pp. 544-556 ◽  
Author(s):  
Magdalena Wadowska ◽  
Julie Woods ◽  
Magdalena Rogozinska ◽  
Teresita L. Briones
1998 ◽  
Vol 37 (10-11) ◽  
pp. 1211-1222 ◽  
Author(s):  
Michael J O'Neill ◽  
Ann Bond ◽  
Paul L Ornstein ◽  
Mark A Ward ◽  
Caroline A Hicks ◽  
...  

PLoS ONE ◽  
2007 ◽  
Vol 2 (5) ◽  
pp. e475 ◽  
Author(s):  
Francesca Ciucci ◽  
Elena Putignano ◽  
Laura Baroncelli ◽  
Silvia Landi ◽  
Nicoletta Berardi ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 41
Author(s):  
Silvia Claros ◽  
Pablo Cabrera ◽  
Nadia Valverde ◽  
Silvana Y. Romero-Zerbo ◽  
Manuel Víctor López-González ◽  
...  

Stress seems to contribute to Parkinson’s disease (PD) neuropathology, probably by dysregulation of the hypothalamic–pituitary–adrenal axis. Key factors in this pathophysiology are oxidative stress and mitochondrial dysfunction and neuronal glucocorticoid-induced toxicity. The insulin-like growth factor II (IGF-II), a pleiotropic hormone, has shown antioxidant and neuroprotective effects in some neurodegenerative disorders. Our aim was to examine the protective effect of IGF-II on a dopaminergic cellular combined model of PD and mild to moderate stress measuring oxidative stress parameters, mitochondrial and neuronal markers, and signalling pathways. IGF-II counteracts the mitochondrial-oxidative damage produced by the toxic synergistic effect of corticosterone and 1-methyl-4-phenylpyridinium, protecting dopaminergic neurons from death and neurodegeneration. IGF-II promotes PKC activation and nuclear factor (erythroid-derived 2)-like 2 antioxidant response in a glucocorticoid receptor-dependent pathway, preventing oxidative cell damage and maintaining mitochondrial function. Thus, IGF-II is a potential therapeutic tool for treatment and prevention of disease progression in PD patients suffering mild to moderate emotional stress.


2007 ◽  
Vol 51 (8) ◽  
pp. 451-458 ◽  
Author(s):  
Dariusz C. Górecki ◽  
Małgorzata Beręsewicz ◽  
Barbara Zabłocka

2012 ◽  
Vol 24 (10) ◽  
pp. 1304-1310 ◽  
Author(s):  
P. Luciani ◽  
C. Deledda ◽  
S. Benvenuti ◽  
I. Cellai ◽  
G. Modi ◽  
...  

1997 ◽  
Vol 760 (1-2) ◽  
pp. 170-178 ◽  
Author(s):  
Michael J O' Neill ◽  
Caroline Hicks ◽  
Mark Ward ◽  
Jill A Panetta

Sign in / Sign up

Export Citation Format

Share Document